sumatriptan has been researched along with Kidney Diseases in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sumatriptan is a potent serotonin 5HT(1B/1D) agonist widely used in the treatment of migraine; the effectiveness of the intranasal formulation (20mg) has been well established in several clinical studies." | 2.41 | Clinical pharmacokinetics of intranasal sumatriptan. ( Barrow, A; Fuseau, E; Ibbotson, T; Moore, KH; Petricoul, O, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuseau, E | 1 |
| Petricoul, O | 1 |
| Moore, KH | 1 |
| Barrow, A | 1 |
| Ibbotson, T | 1 |
1 review available for sumatriptan and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of intranasal sumatriptan.
Topics: Administration, Intranasal; Adolescent; Adult; Animals; Child; Clinical Trials as Topic; Dose-Respon | 2002 |